Doximity Inc (NYSE: DOCS) on Tuesday, plunged -0.85% from the previous trading day, before settling in for the closing price of $24.79. Within the past 52 weeks, DOCS’s price has moved between $19.71 and $37.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 50.40%. The company achieved an average annual earnings per share of 23.04%. With a float of $117.86 million, this company’s outstanding shares have now reached $120.68 million.
Let’s determine the extent of company efficiency that accounts for 977 employees.
Doximity Inc (DOCS) Insider Activity
Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Doximity Inc is 36.83%, while institutional ownership is 49.65%. The most recent insider transaction that took place on Apr 01 ’24, was worth 67,425. In this transaction Director of this company sold 2,500 shares at a rate of $26.97, taking the stock ownership to the 10,258 shares. Before that another transaction happened on Mar 01 ’24, when Company’s Director sold 2,500 for $27.88, making the entire transaction worth $69,700. This insider now owns 10,258 shares in total.
Doximity Inc (DOCS) Earnings and Forecasts
As on 12/31/2023, Multinational firm has announced its last quarter scores, in which it reported 0.2 earnings per share (EPS) for the period topping the consensus outlook (set at 0.17) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.55% during the next five years compared to 255.76% growth over the previous five years of trading.
Doximity Inc (NYSE: DOCS) Trading Performance Indicators
Doximity Inc (DOCS) is currently performing well based on its current performance indicators. A quick ratio of 7.97 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.79. Likewise, its price to free cash flow for the trailing twelve months is 27.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.66, a number that is poised to hit 0.20 in the next quarter and is forecasted to reach 0.95 in one year’s time.
Technical Analysis of Doximity Inc (DOCS)
Looking closely at Doximity Inc (NYSE: DOCS), its last 5-days average volume was 1.28 million, which is a drop from its year-to-date volume of 1.74 million. As of the previous 9 days, the stock’s Stochastic %D was 13.43%. Additionally, its Average True Range was 0.76.
During the past 100 days, Doximity Inc’s (DOCS) raw stochastic average was set at 16.51%, which indicates a significant increase from 9.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.63% in the past 14 days, which was lower than the 34.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.37, while its 200-day Moving Average is $26.26. However, in the short run, Doximity Inc’s stock first resistance to watch stands at $24.97. Second resistance stands at $25.36. The third major resistance level sits at $25.57. If the price goes on to break the first support level at $24.37, it is likely to go to the next support level at $24.16. Should the price break the second support level, the third support level stands at $23.77.
Doximity Inc (NYSE: DOCS) Key Stats
Market capitalization of the company is 4.59 billion based on 186,554K outstanding shares. Right now, sales total 419,050 K and income totals 112,820 K. The company made 135,280 K in profit during its latest quarter, and 47,960 K in sales during its previous quarter.
